Skip to content

Assistant to activate patients with dementia and their caregivers

Assistant to activate patients with dementia and their caregivers - MobiAssist

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
DRKS
Registry ID
DRKS00013638
Enrollment
45
Registered
2018-02-01
Start date
2017-12-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F00 F01

Interventions

Group 1: Control phase of 16 weeks, no treatment, usual care (prescribed medications, exercise therapy and other therapies will be retained, continuation of all activities as far as possible). Afterwa

Sponsors

Ambulante Diakonische Dienste gGmbH
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) type of dementia: Alzheimer’s disease or vascular dementia; diagnosed by professionals in memory clinic (CERAD neuropsychological battery); alternative for Siegen: Clinical Dementia Rating (CDR; Morris, 1993) value > 0.5 2) give consent 3) participants are retired 4) participants are mobile and able to stand up from a chair without support and walk 6m 5) care dependency measured by barthel index (BI): criteria: BI< 60 points (Mahoney & Barthel, 1965) 6) support by a professional caregiver or by an informal caregiver 7) written informed consent from patient with dementia and the informal caregiver 8) medical certification 9) cognitive and social requirements (interested, motivated, no aggressive behavior, can imitate exercises, understand simple verbal information, control of emotional reactions) 10) physical requirements (routine actions can be completed; also he/she can: see, hear, speak, sit and stand up, walk, grab and hold on a chair) 11) conditions of the environments (TV with HDMI, wireless internet at home)

Exclusion criteria

Exclusion criteria: 1) other types of dementia (frontotemporal dementia, dementia with Lewy bodies, alcohol-relates brain damage (Korsakoff´s syndrome), familial Alzheimer's disease) 2) mental disorders like depression or generalized anxiety disorder who have not been satisfactorily medicated for at least six months; substance-related disorders in the last 2 years; schizophrenia and other psychological disorders 3) neurodegenerative diseases of the Central Nervous System (CNS), Parkinson’s disease, multiple sclerosis, Amyotrophic Lateral Sclerosis (ALS) 4) cardiovascular diseases: acute cardiac failure, acute cardiac insufficiency, angina pectoris, untreated cardiac arrhythmia or heart valve disease, pacemaker, untreated hypertension - systolic blood pressure >180 mm Hg or diastolic blood pressure > 110 mm Hg; untreated hypotension - 15 mmol/L) 8) epilepsy 9) Chronic Obstructive Pulmonary Disease (COPD) grade 4 10) acute infection or fever 11) acute renal insufficiency 12) osteoporosis 13) surgical interventions in the last 6 months 14) taking neuroleptics or benzodiazepine 15) participation in another study for dementia

Design outcomes

Primary

MeasureTime frame
Functional status and the extent of support effort using Barthel-Index (Hamburg Classification Manual). Periods: December 2017 until January 2018 (T0), March until April 2018 (T1), July until August 2018 (T2).

Secondary

MeasureTime frame
1) Extended Barthel-Index (Mahoney & Barthel, 1965). 2) Physical performance (endurance, strength, balance, gait speed, chair stand, mobility) using Short Physical Performance Battery (Guralnik et al., 1994) and Senior Fitness Test (Rikli & Jones, 1999). 3) Cognitive performance (processing speed, memory, working memory, word fluency) using Trail-Making-Test A (Tischler & Petermann, 2010) and DemTect (Kalbe et al., 2004; Kessler et al., 2000). 4) Quality of Life using Quality of Living-AD (Logsdon, 1999). 5) Leasure time activities using PASE (Washburn et al., 1991). 6) Aspects of Usability using System Usability Scale (Brooke, 1996), DART (Amberg et al., 2003) and User Experience Questionnaire (Laugwitz et al., 2008). 7) Trainingadherence (Mode, frequency, duration, level of all single Exergames). 8) Effects of the system/using of technology on aspects of care and daily life using interviews. Periods: 1)-5): December 2017 until January 2018 (T0), March until April 2018 (T1), July until August 2018 (T2). 6)+7) March until August 2018 (Interventionphase). 8): July until August 2018 (T2).

Countries

Germany

Contacts

Public ContactSabine Eichberg

Deutsche Sporthochschule Köln

eichberg@dshs-koeln.de+49-221-49826145

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026